Results 131 to 140 of about 4,653 (155)

Summary of opinion: Febuxostat Krka,febuxostat

Case Medical Research, 2019
openaire   +2 more sources

Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial

Lancet, The, 2020
Thomas Macdonald, Stuart H Ralston, Isla Mackenzie   +2 more
exaly  

Efficacy and tolerability of febuxostat in gout patients on dialysis

Internal Medicine Journal, 2021
Doo-Ho Lim
exaly  

Febuxostat

Reactions Weekly, 2021
openaire   +1 more source

Celebrating Versatility: Febuxostat’s Multifaceted Therapeutic Application

Life, 2023
Krasimir Kraev, Mariela Geneva-Popova, Bozhidar Hristov   +2 more
exaly  

Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy

European Heart Journal, 2019
Yoshihiko Saito, Kunihiko Matsui, Kazuo Kimura   +2 more
exaly  

Febuxostat

Reactions Weekly, 2023
openaire   +1 more source

The net clinical benefits of febuxostat versus allopurinol in patients with gout or asymptomatic hyperuricemia – A systematic review and meta-analysis

Nutrition, Metabolism and Cardiovascular Diseases, 2019
Cheng-Wei Liu, , Fu-Shun Hsu
exaly  

Febuxostat

Reactions Weekly, 2012
  +4 more sources

Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study

Rheumatology, 2009
M A Becker, H R Schumacher
exaly